Abated cardiovascular responses to chronic oral lisinopril treatment in conscious elderly rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 276, Issue 5 45-5, 1999, Pages

  Buñag, Ruben ^a   Mellick, Jennifer ^a   Allen, Brandy ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Age; Conscious rats; Pressor responsiveness; Reflex bradycardia

Indexed keywords

LISINOPRIL;

AGE; ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CARDIOVASCULAR REFLEX; CONTROLLED STUDY; DRUG EFFECT; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT;

EID: 18244417819     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.276.5.r1408     Document Type: Article

References (35)

1. Belmin, J., B. I. Levy, and J. B. Michel. Changes in the renin-angiotensin-aldosterone axis in later life. Drugs Aging 5: 391-400, 1994.
2. Berecek, K. H., J. D. Robertson, and M. H. Thorstad. Central administration of a specific angiotensin II receptor antagonist on baroreflex function in spontaneously hypertensive rats. J. Hypertens. 9: 365-371, 1991.
3. Bruning, J. L., and B. L. Kintz. Computational Handbook of Statistics. Glenview, IL: Foresman, 1987, p. 18-109.
4. Buñag, R. D. Hypertensive rat models for diabetes, obesity, or aging. In: Experimental and Genetic Aspects of Hypertension, edited by D. Ganten and W. de Jong. Amsterdam, The Netherlands: Biomedical, 1994, vol. 4, p. 118-140.
5. Buñag, R. D., M. Meyer, N. Vansell, and L. Kerecsen. Conscious obese rats have impaired reflex bradycardia and enhanced norepinephrine sensitivity. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R654-R660, 1996.
6. Buñag, R. D., and T. Teravainen. Waning cardiovascular responses to adrenergic drugs in conscious ageing rats. Mech. Ageing Dev. 61: 313-326, 1991.
7. Buñag, R. D., T. Teravainen, and L. Eriksson. Enhanced sympathetic mediation of chronotropic baroreflexes in old Sprague-Dawley rats. Mech. Ageing Dev. 53: 195-208, 1990.
8. Case, D. E. The clinical pharmacology of lisinopril. J. Hum. Hypertens. 3: 127-131, 1989.
9. Corea, L., M. Bentivoglio, P. Verdecchia, and M. Provvidenza. Converting enzyme inhibition versus diuretic therapy as first therapeutic approach to the elderly hypertensive patient. Curr. Ther. Res. 36: 347-351, 1984.
10. Davidow, L. W., and R. D. Buñag. Hypotensive and reflex bradycardic effects of ketanserin, but not of prazosin, enhanced selectively in aging conscious rats. J. Cardiovasc. Pharmacol. 28: 294-301, 1996.
11. Ebert, T. J. Captopril potentiates chronotropic baroreflex responses to carotid stimuli in humans. Hypertension 7: 602-606, 1985.
12. Egan, B. M., M. J. Fleissner, K. Stepniakowski, J. M. Neahring, K. B. Sagar, and T. J. Ebert. Improved baroreflex sensitivity in elderly hypertensives on lisinopril is not explained by blood pressure reduction alone. J. Hypertens. 11: 1113-1120, 1993.
13. Eriksson, L., L. Kerecsen, and R. D. Buñag. Strain differences in baroreflex inhibition by centrally infused enalapril in old rats. J. Gerontol. A Biol. Sci. Med. Sci. 46: B65-B71, 1991.
14. Ferrario, C. M., N. Jaiswal, K. Yamamoto, D. I. Diz, and M. T. Schiavone. Hypertensive mechanisms and converting enzyme inhibitors. Clin. Cardiol. 14: 56-62, 1991.
15. Fruncillo, R. J., H. H. Rotmensch, P. H. Vlasses, J. R. Koplin, B. N. Swanson, and R. K. Ferguson. Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives. Eur. J. Clin. Pharmacol. 28: 5-9, 1985.
16. Gribbin, B., T. Pickering, P. Sleight, and R. Peto. Effect of age and high blood pressure on baroreflex sensitivity in man. Circ. Res. 24: 424-443, 1971.
17. Hatch, R. C., R. W. Hughes, and H. Bozivich. Effect of resting blood pressure on pressure responses to drugs and carotid occlusion. Am. J. Physiol. 213: 1515-1519, 1967.
18. Hintze, J. L. NCSS 6.0 Statistical System for Windows. Kaysville, UT: NCSS, 1966.
19. Imai, Y., K. Abe, M. Seino, T. Haruyama, J. Tajima, M. Sato, T. Goto, M. Hiwatari, Y. Kasai, K. Yoshinaga, and H. Sekino. Attenuation of pressor responses to norepinephrine and pitressin and potentiation of pressor response to angiotensin II by captopril in human subjects. Hypertension 4: 444-451, 1982.
20. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch. Intern. Med. 157: 2413-2446, 1997.
21. Kondowe, G., A. Deering, J. Riddell, G. Johnston, and D. Harron. The effect of acute and chronic captopril therapy on baroreflex function in man. Br. J. Clin. Pharmacol. 25: 315-321, 1988.
22. Korol, B., and M. L. Brown. Influence of existing arterial pressure on autonomic drug responses. Am. J. Physiol. 213: 112-114, 1967.
23. Kumagai, H., D. B. Averill, and C. M. Ferrario. Renal nerve activity in rats with spontaneous hypertension: effect of converting enzyme inhibitor. Am. J. Physiol. 263 (Regulatory Integrative Comp. Physiol. 32): R109-R115, 1992.
24. Kumagai, K., H. Suzuki, M. Ichikawa, M. Jimbo, M. Nishizawa, M. Ryuzaki, and T. Saruta. Comparison of early and late start of antihypertensive agents and baroreceptor reflexes. Hypertension 27: 209-218, 1996.
25. Laher, M., J. Donohoe, J. Kelly, and G. Doyle. Antihypertensive and renal effects of lisinopril in older patients with hypertension. Am. J. Med. 85: 38-43, 1988.
26. Licker, M., P. Neidhart, S. Lustenberger, M. Valloton, T. Kalonji, M. Fathi, and D. Morel. Long-term angiotensin-converting enzyme inhibitor treatment attentuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery. Anesthesiology 84: 789-800, 1996.
27. Makki, T., R. Talom, N. Neiderhoffer, F. Amin, P. Tankosic, P. Metes, and J. Atkinson. Increased arterial distensibility induced by the angiotensin-converting enzyme inhibitor, lisinopril, in normotensive rats. Br. J. Pharmacol. 111: 555-560, 1994.
28. Montemayor, E., J. Mellick, L. Kerecsen, and R. D. Buñag. Acute lisinopril treatment in old rats worsens impairment of angiotensin-induced reflex bradycardia. J. Cardiovasc. Pharmacol. 30: 510-516, 1997.
29. Muratani, H., Y. Kimura, K. Matsumura, Y. Noda, T. Eto, and K. Fukiyama. Baroreceptor reflex in elderly essential hypertensives: effect of chronic inhibition of angiotensin converting enzyme. Clin. Exp. Hypertens. 12: 97-110, 1990.
30. Rizzoni, D., M. Castellano, E. Porteri, G. Bettoni, M. Muiesan, A. Cinelli, R. Zulli, and E. Rosie. Prolonged effects of short-term fosinopril on blood pressure and vascular morphology and function in rats. Am. J. Hypertens. 10: 1034-1043, 1997.
31. Rosendorff, C., J. Patton, H. Radford, and B. Kalliatakis. α-Adrenergic and angiotensin II pressor sensitivity in hypertensive patients treated with an angiotensin-converting enzyme inhibitor. J. Cardiovasc. Pharmacol. 19: S105-S109, 1992.
32. Spertini, F., H. Brunner, B. Waeber, and H. Gavras. The opposing effects of chronic angiotensin-converting enzyme blockade by captorpil on the responses to exogenous angiotensin II and vasopressin vs norepinephrine in rats. Circ. Res. 48: 612-618, 1981.
33. Weinstock, M., and E. Gorodetsky. Comparison of the effects of angiotensin II, losartan, and enalapril on baroreflex control of heart rate in conscious rabbits. J. Cardiovasc. Pharmacol. 25: 501-507, 1995.
34. Weiss, G. B., B. Sturm, and N. Levens. Rapid reversal of angiotensin I-induced contractions in rat carotid arteries after acute and chronic treatment with the angiotensin-converting enzyme inibitor, 3-[(5-amino-1-carboxy-1S-pentyl)amino]2,3,4,5-tetrahydro-2-oxo-3S-1H-1-acetic acid (CGS 16617). J. Pharmacol. Exp. Ther. 267: 1407-1413, 1993.
35. Wilder, J. Basimetric approach (law of initial value) to biological rhythms. Ann. NY Acad. Sci. 98: 1211-1220, 1962.